Nervous System Drug-by-design: Formulation May Slow Parkinson's, Alzheimer's, Huntington's, Tel Aviv University Study

ScienceDaily — Working like an architect, Prof. Hagit Eldar-Finkelman of Tel Aviv University's Sackler School of Medicine is "building" a new drug, L803-MTS, to treat a number of central nervous system (CNS) diseases like Alzheimer's. In pre-clinical studies, it also shows promise against Parkinson's, Huntington's and diabetes.

Back to news